References
- Samarasekera EJ, Sawyer L, Wonderling D, et al. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses. Br J Dermatol. 2013;168:954–67.
- Lamba S, Lebwohl M. Combination therapy with vitamin D analogues. Br J Dermatol. 2001;144:27–32.
- Pathirana D, Ormerod AD, Saiag P, et al. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2009;23:1–70.
- Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011;65:137–74.
- Lowe NJ. Optimizing therapy: tazarotene in combination with phototherapy. Br J Dermatol. 1999;140:8–11.
- Molin L. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group. Dermatology. 1999;198:375–81.
- Ramsay CA, Schwartz BE, Lowson D, et al. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. Dermatology. 2000;200:17–24.
- Veien NK, Bjerke JR, Rossmann-Ringdahl I, et al. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol. 1997;137:581–6.
- Van de Kerkhof PC, Werfel T, Haustein UF, et al. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol. 1996;135:758–65.
- Scarpa C. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis. J Eur Acad Dermatol Venereol. 1996;6:142–6.
- Rai R, Srinivas CR. Phototherapy: an Indian perceptive. Indian J Dermatol. 2007;52:169–75.
- Honigsmann H, Krutmann J. Practical guidelines for broadband UVB, narrowband UVB, UVA-1 phototherapy, and PUVA photochemotherapy – a proposal. In Krutmann J, Honigsmann H, Clements A, Bergstresser P, eds. Dermatological Phototherapy and Photodiagnostic methods. New York: Springer, 2001. p 371.
- Lebwohl M, Hecker D, Martinez J, et al. Interactions between calcipotriene and ultraviolet light. J Am Acad Dermatol. 1997;37:93–5.
- Das S, Lloyd JJ, Walshaw D, et al. Response of psoriasis to sunbed treatment: comparison of conventional ultraviolet A lamps with new higher ultraviolet B-emitting lamps. Br J Dermatol. 2002;147:966–72.
- Guilhou JJ. The therapeutic effects of vitamin D3 and its analogues in psoriasis. Expert Opin Investig Drugs. 1998;7:77–84.
- Brands S, Brakman M, Bos JD, et al. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis. J Am Acad Dermatol. 1999;41:991–5.
- McKenna KE, Stern RS. Photosensitivity associated with combined UV-B and calcipotriene therapy. Arch Dermatol. 1995;131:1305–7.
- Lambert J, Trompke C. Tacalcitol ointment for long-term control of chronic plaque psoriasis in dermatological practice. Dermatology. 2002;204:321–4.
- Foti C, Carnimeo L, Bonamonte D, et al. Tolerance to calcitriol and tacalcitol in three patients with allergic contact dermatitis to calcipotriol. J Drugs Dermatol. 2005;4:756–9.
- Kokelj F, Plozzer C, Guadagnini A. Topical tacalcitol reduces the total UVB dosage in the treatment of psoriasis vulgaris. J Dermatol Treat. 1996;7:265–6.
- Messer G, Degitz K, Plewig G, Rocken M. Pretreatment of psoriasis with the vitamin D3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br J Dermatol. 2001;144:628–9.
- Brazzelli V, Barbagallo T, Prestinari F, et al. Non-invasive evaluation of tacalcitol plus puva versus tacalcitol plus UVB-NB in the treatment of psoriasis: “right-left intra-individual pre/post comparison design”. Int J Immunopathol Pharmacol. 2005;18:755–60.
- Prignano F, Buggiani G, Lotti T. Clinical evaluation of topical tacalcitol efficacy in extending the remission period between nb-UVB phototherapy cycles in psoriatic patients. Acta Biomed. 2009;80:51–6.